← All startups
Alpha-9 Oncology
Clinical-stage radiopharma pipeline of peptide-based, best-in-class oncology therapies
Latest roundFunding roundOct 1, 2024
Team32
NameLocationLinksContact
Alison Fleming
COO
—
—
Paul Blanchfield
Chief Executive Officer
Greater Boston
—
Robert Meehan
Chief Medical Officer
Cambridge, Massachusetts, United States
—
Stephen Mitchener
Chief Business Officer
Cambridge, Massachusetts, United States
—
Mark Dornan
Vice President
Toronto, Ontario, Canada
—
Alessandra Barone
Associate Director
—
—
Alexander Butte
Sr Director
—
—
Andrew Groark
Director
—
—
Andrew Hong
Director
—
—
Chengcheng Zhang
Director
—
—
Chethana Naik
Senior Director Quality Assurance
—
—
Jas Hundal
Senior Director Finance
—
—
Jean-François Vincent-Rocan
Associate Director
—
—
Julie Rousseau
Head of Translational Biology
—
—
Katherine Li
Executive Director Business Development
—
—
Mark Lovell
Sr Director
—
—
Matthew Lau
Associate Director
—
—
Megan Bumgarner
Director
—
—
Oyuntuya Munkhbat
Director
—
—
Parita Patel
Senior Director Clinical Operations
—
—
Sandra Fernando
Associate Director Clinical Supply Chain
—
—
Stephen H.
Sr Director
—
—
Thomas Kostelnik
Director
—
—
Valerie Miakushko
Director
—
—
William Miller
Director of Diagnostic Radiopharmaceutical Deve…
—
—
Brendan Grosse
Senior Manager
—
—
Iris Miu
Senior Clinical Trial Manager
—
—
Michael A. Morris
Senior Manager of Intellectual Property
—
—
Nada Mahfouz
Senior Manager
—
—
Pau-Lin Ngen
Senior Manager
—
—
Riley Smith
Radiation Safety Officer
—
—
Michael Reitermann
Member Board of Directors
New York City Metropolitan Area
—